IDiyas

For the Inventor, By the Inventor

Kato, Japan

Takashi Ogino

USPTO Granted Patents = 20

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 88(Granted Patents)


Location History:

  • Kobe, JP (1980 - 1994)
  • Yamatokoriyama, JP (2001)
  • Katoh-gun, JP (2001)
  • Yamatokooriyama, JP (1996 - 2005)
  • Osaka, JP (2005)
  • Hyogo, JP (2011)
  • Kato, JP (2012 - 2016)

Company Filing History:

goldMedal12 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents
silverMedal8 out of 148 
 
Nippon Zoki Pharmaceutical Co., Ltd.
 patents

Years Active: 1980-2016

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 9365533 - Coumarin derivative (2016-06-14),
2. 8653285 - Aminopropylidene derivative (2014-02-18),
3. 8536342 - Process for producing thiabenzoazulene-propionic acid derivative (2013-09-17),
4. 8377967 - Piperidine derivative (2013-02-19),
5. 8222419 - Oxepin derivative (2012-07-17),
6. 7939552 - Benzyloxypropylamine derivative (2011-05-10),
7. 6906074 - 2-phenylpiperazine derivatives (2005-06-14),
8. 6884868 - Cyclic hexapeptides having antibiotic activity (2005-04-26),
9. 6884774 - Cyclic hexapeptide derivatives (2005-04-26),
10. 6316485 - 1,5-diphenylpyrazole derivatives (2001-11-13),
11. 6242452 - 7-aminopyrido[2,3-D]pyrimidine derivatives (2001-06-05),
12. 5670533 - Pyrazole derivatives, processes for preparation thereof and (1997-09-23),
13. 5550147 - Pyrazole derivatives, processes for preparation thereof and (1996-08-27),
14. 5369107 - Thiazole derivatives, processes for production thereof and (1994-11-29),
15. 5256675 - Thiazole derivatives, processes for production thereof and (1993-10-26),

Title: **Innovative Contributions of Takashi Ogino in Pharmaceutical Patents**

Introduction

Takashi Ogino, an esteemed inventor located in Kato, Japan, has made significant strides in the pharmaceutical field with a remarkable portfolio of 20 patents. His contributions have not only advanced scientific knowledge but have also paved the way for potential therapeutic solutions to common ailments.

Latest Patents

Among his latest innovations, Ogino holds a patent for a **Coumarin Derivative**, which is described as a novel compound or its pharmaceutically acceptable salt. This compound has demonstrated excellent suppressive action against cartilage destruction and inhibits the proliferation of synovial cells, making it a promising active ingredient for pharmacological compositions aimed at combating conditions such as osteoarthritis and chronic rheumatoid arthritis.

Another noteworthy patent is his **Aminopropylidene Derivative**, recognized for its exceptional histamine receptor antagonistic action. This compound is particularly valuable for its potential as a pharmaceutical ingredient that may alleviate side effects in the central nervous system, addressing a critical need in drug development.

Career Highlights

Throughout his career, Takashi Ogino has been affiliated with leading companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company and Nippon Zoki Pharmaceutical Co., Ltd. His involvement with these organizations has been instrumental in the development of several groundbreaking pharmaceutical innovations.

Collaborations

Ogino has collaborated with notable peers in the industry, including Kunihiko Higashiura and Takao Takaya. These partnerships have fostered a dynamic environment for innovative research and development, advancing the field of pharmaceuticals.

Conclusion

In conclusion, Takashi Ogino's contributions to the pharmaceutical sector through his inventive patents and collaborations highlight his role as a key player in addressing health challenges. His work not only showcases his dedication to innovation but also holds promise for improving therapeutic options available for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…